Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

AMPE Relative to the S&P 500

AMPE Relative to the Sector

Seasonal Chart Analysis

Analysis of the Ampio Pharmaceuticals, Inc. (OTCMKT:AMPE) seasonal charts above shows that a Buy Date of November 14 and a Sell Date of February 8 has resulted in a geometric average return of 22.11% above the benchmark rate of the S&P 500 Total Return Index over the past 16 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 16 years by an average of 122.11% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.

To download AMPE seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: AMPE